Clinical Trials
2 trialsNCT05971758 2025-07-04
Fimepinostat, Combination HDAC and Pi3-kinase Inhibitor Tumor-Directed Therapy for Cushing Disease
University of California, Los Angeles
Phase 2 Recruiting
NCT00612066 2020-08-06
Rosiglitazone in Treating Patients With Newly Diagnosed ACTH-Secreting Pituitary Tumor (Cushing Disease)
Jonsson Comprehensive Cancer Center
Phase 2 Terminated